Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$79.4 - $116.36 $38,509 - $56,434
-485 Reduced 8.15%
5,466 $436,000
Q1 2022

Apr 26, 2022

SELL
$86.42 - $109.81 $49,605 - $63,030
-574 Reduced 8.8%
5,951 $626,000
Q4 2021

Mar 11, 2022

BUY
$98.56 - $119.91 $34,397 - $41,848
349 Added 5.65%
6,525 $704,000
Q3 2021

Oct 15, 2021

BUY
$91.91 - $110.37 $567,636 - $681,645
6,176 New
6,176 $677,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track First Citizens Bank & Trust CO Portfolio

Follow First Citizens Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Bank & Trust CO with notifications on news.